Tenet Healthcare Corporation New
Here’s whether Tenet Healthcare Corporation New (THC) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Caution.
Positives: RSI 42 — healthy momentum range; strong 1-year return of +26.1%. Concerns: trading below the 200-day MA (long-term downtrend); below the 50-day MA (medium-term momentum negative); 50-day MA is falling (-3.06% over 10 days); rising volume on a downtrend (distribution, 1.45x avg). Currently 25.9% off its 52-week high. Score: -2/7.
THC is trading below its 200-day MA ($197.01) — a key warning sign the longer-term trend is under pressure. An RSI of 42.5 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of +26.1% compares to +27.9% for SPY (trailed the market by 1.7%). The current 25.9% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.